Risk factors for severe bacterial infections in patients with systemic autoimmune diseases receiving rituximab

The risk of serious bacterial infectious events (SIEs) after an RTX course used in severe and refractory cases of systemic autoimmune diseases (SAID) is well known. Risk factors for SIEs merit investigation. For this case–control study, data were collected in a single centre of internal medicine and...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Heusele, Marion, Clerson, Pierre, Guery, Benoit, Lambert, Marc, Launay, David, Lefevre, Guillaume, Morell-Dubois, Sandrine, Maillard, Hélène, Le Gouellec, Noémie, Hatron, Pierre-Yves, Hachulla, Eric
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer London 2014
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4058071/
https://ncbi.nlm.nih.gov/pubmed/24487486
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10067-014-2509-2
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller